FdaApplication

ANDA 075227

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date1998-06-30

Products (2)

ProductActive ingredientStrengthDosage form
NAPROXENNAPROXEN500MGTABLET, DELAYED RELEASE;ORAL
NAPROXENNAPROXEN375MGTABLET, DELAYED RELEASE;ORAL

2 products